Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery.

The plasma membrane as a selectively permeable barrier of living cells is essential to cell survival and function. In many cases, however, the efficient passage of exogenous bioactive molecules through the plasma membrane remains a major hurdle for intracellular delivery of cargoes. During the last two decades, the potential of peptides for drug delivery into cells has been highlighted by the discovery of numerous cell-penetrating peptides (CPPs). CPPs serving as carriers can successfully intracellular transport cargoes such as siRNA, nucleic acids, proteins, small molecule therapeutic agents, quantum dots and MRI contrast agents. This review mainly introduces recent advances of CPPs as new carriers for the development of cellular imaging, nuclear localization, pH-sensitive and thermally targeted delivery systems. In particular, we highlight the exploiting of the synergistic effects of targeting ligands and CPPs. What's more, the classification and cellular uptake mechanisms of CPPs are briefly discussed as well.

[1]  Christopher J. Cheng,et al.  Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. , 2011, Biomaterials.

[2]  M. Dec,et al.  Antimicrobial activity of , 2016 .

[3]  Jim Euchner Design , 2014, Catalysis from A to Z.

[4]  S. Futaki,et al.  Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells. , 2013, Molecular bioSystems.

[5]  C. Joe,et al.  Folate receptor-mediated intracellular delivery of recombinant caspase-3 for inducing apoptosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Scott Banta,et al.  An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform. , 2011, ACS chemical biology.

[7]  C. I. Smith,et al.  Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions , 2012, Journal of Controlled Release.

[8]  Ulo Langel,et al.  Cell-penetrating peptides: mechanism and kinetics of cargo delivery. , 2005, Advanced drug delivery reviews.

[9]  T. Kissel,et al.  Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer , 2003, The journal of gene medicine.

[10]  David Piwnica-Worms,et al.  Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model , 2009, Proceedings of the National Academy of Sciences.

[11]  T. Park,et al.  RGD targeting hyaluronic acid coating system for PEI-PBLG polycation gene carriers. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[12]  G. Wong,et al.  Arginine‐rich cell‐penetrating peptides , 2010, FEBS letters.

[13]  H. Chen,et al.  The nuclear localization signal sequence of porcine circovirus type 2 ORF2 enhances intracellular delivery of plasmid DNA , 2011, Archives of Virology.

[14]  J. Chmielewski,et al.  Cationic Amphiphilic Polyproline Helices: Side‐Chain Variations and Cell‐Specific Internalization , 2009, Chemical Biology and Drug Design.

[15]  J. Ochocki,et al.  Evaluation of a cell penetrating prenylated peptide lacking an intrinsic fluorophore via in situ click reaction. , 2011, Bioorganic & medicinal chemistry letters.

[16]  P. Boisguérin,et al.  Comparison of cellular uptake using 22 CPPs in 4 different cell lines. , 2008, Bioconjugate chemistry.

[17]  B. Lebleu,et al.  Cellular Uptake of Unconjugated TAT Peptide Involves Clathrin-dependent Endocytosis and Heparan Sulfate Receptors* , 2005, Journal of Biological Chemistry.

[18]  M. Ferrer,et al.  Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. , 2005, Biochimica et biophysica acta.

[19]  Ű. Langel,et al.  Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. , 2006, Current opinion in pharmacology.

[20]  James F. Leary,et al.  Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. , 2012, Biomaterials.

[21]  Donald M. O'Rourke,et al.  Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo , 2000, Nature Biotechnology.

[22]  Ű. Langel,et al.  N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis. , 2006, Biochemical and biophysical research communications.

[23]  R. Stern Hyaluronidases in cancer biology. , 2008, Seminars in cancer biology.

[24]  Jun Yao,et al.  Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide. , 2006, Cancer research.

[25]  Simon W. Jones,et al.  Characterisation of cell‐penetrating peptide‐mediated peptide delivery , 2005, British journal of pharmacology.

[26]  Kyung-Soo Hahm,et al.  Antimicrobial activity, bactericidal mechanism and LPS‐neutralizing activity of the cell‐penetrating peptide pVEC and its analogs , 2011, Journal of peptide science : an official publication of the European Peptide Society.

[27]  Irene Martín,et al.  Design, Synthesis and Characterization of a New Anionic Cell‐Penetrating Peptide: SAP(E) , 2011, Chembiochem : a European journal of chemical biology.

[28]  S. Futaki,et al.  Arginine-rich peptides and their internalization mechanisms. , 2007, Biochemical Society transactions.

[29]  Iqbal Massodi,et al.  Application of Thermally Responsive Elastin-like Polypeptide Fused to a Lactoferrin-derived Peptide for Treatment of Pancreatic Cancer , 2009, Molecules.

[30]  Yue-Wern Huang,et al.  Mechanistic studies of intracellular delivery of proteins by cell-penetrating peptides in cyanobacteria , 2013, BMC Microbiology.

[31]  R. Tsien,et al.  In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[32]  M. Morris,et al.  Cell‐penetrating peptides: from molecular mechanisms to therapeutics , 2008, Biology of the cell.

[33]  Sei Kwang Hahn,et al.  Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. , 2011, ACS nano.

[34]  Shana O Kelley,et al.  Recent advances in the use of cell-penetrating peptides for medical and biological applications. , 2009, Advanced drug delivery reviews.

[35]  A. Eguchi,et al.  siRNA delivery using peptide transduction domains. , 2009, Trends in pharmacological sciences.

[36]  G. W. Vuister,et al.  A Cell-penetrating Peptide Derived from Human Lactoferrin with Conformation-dependent Uptake Efficiency , 2009, The Journal of Biological Chemistry.

[37]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[38]  Y. Yoshioka,et al.  Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide. , 2007, Biochemical and biophysical research communications.

[39]  C. le Grimellec,et al.  Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes. , 2004, Biochemistry.

[40]  M. Mano,et al.  S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells. , 2010, Bioconjugate chemistry.

[41]  Ű. Langel,et al.  Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. , 2006, Biochemical pharmacology.

[42]  M. Akashi,et al.  Fibroblast Growth Factor-12 (FGF12) Translocation into Intestinal Epithelial Cells Is Dependent on a Novel Cell-penetrating Peptide Domain , 2011, The Journal of Biological Chemistry.

[43]  Robert Langer,et al.  Targeted nanoparticles for cancer therapy , 2007 .

[44]  D. Raucher,et al.  A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells* , 2007, Journal of drug targeting.

[45]  Tianyue Jiang,et al.  Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. , 2012, Biomaterials.

[46]  G. Tang,et al.  Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginine. , 2011, Biomaterials.

[47]  E. Giralt,et al.  Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein. , 2004, Angewandte Chemie.

[48]  M. Hong,et al.  Asymmetric insertion of membrane proteins in lipid bilayers by solid-state NMR paramagnetic relaxation enhancement: a cell-penetrating Peptide example. , 2008, Journal of the American Chemical Society.

[49]  R. Vandenbroucke,et al.  Cellular entry pathway and gene transfer capacity of TAT-modified lipoplexes. , 2007, Biochimica et biophysica acta.

[50]  S. Futaki,et al.  Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[51]  J. Rothbard,et al.  Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation , 2000, Nature Medicine.

[52]  Ü. Langel,et al.  Delivery of short interfering RNA using endosomolytic cell‐penetrating peptides , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  Joel A. Cohen,et al.  Enhanced cell penetration of acid-degradable particles functionalized with cell-penetrating peptides. , 2008, Bioconjugate chemistry.

[54]  Henrik J Johansson,et al.  Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[55]  Yasuyoshi Watanabe,et al.  Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[56]  Kurt Ballmer-Hofer,et al.  Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans* , 2003, Journal of Biological Chemistry.

[57]  S. Futaki,et al.  Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. , 2008, Advanced drug delivery reviews.

[58]  S. Futaki,et al.  Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment , 2009, The AAPS Journal.

[59]  Glenn Walter,et al.  Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. , 2005, Chemical communications.

[60]  R. Artero,et al.  A conserved motif controls nuclear localization of Drosophila Muscleblind , 2010, Molecules and cells.

[61]  S. Futaki,et al.  Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[62]  C. Beattie,et al.  Noncationic peptides obtained from azurin preferentially enter cancer cells. , 2009, Cancer research.

[63]  André Pèlegrin,et al.  Cell-penetrating and cell-targeting peptides in drug delivery. , 2008, Biochimica et biophysica acta.

[64]  Satyajit Mayor,et al.  Pathways of clathrin-independent endocytosis , 2007, Nature Reviews Molecular Cell Biology.

[65]  Ick Chan Kwon,et al.  Self-assembled hyaluronic acid nanoparticles for active tumor targeting. , 2010, Biomaterials.

[66]  T. Tarragó,et al.  all-D proline-rich cell-penetrating peptides: a preliminary in vivo internalization study. , 2007, Biochemical Society transactions.

[67]  Yue-Wern Huang,et al.  Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism. , 2011, Biomaterials.

[68]  I. Mäger,et al.  In vivo biodistribution and efficacy of peptide mediated delivery. , 2010, Trends in pharmacological sciences.

[69]  Miriam Scadeng,et al.  Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.

[70]  P. Iversen,et al.  Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–activity studies , 2008, Nucleic acids research.

[71]  B. Wiesner,et al.  Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.

[72]  L. Khachigian,et al.  Nuclear import of early growth response-1 involves importin-7 and the novel nuclear localization signal serine-proline-serine. , 2011, The international journal of biochemistry & cell biology.

[73]  J. M. Kumar,et al.  Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate. , 2012, Biomaterials.

[74]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[75]  G. Divita,et al.  Direct Translocation as Major Cellular Uptake for CADY Self-Assembling Peptide-Based Nanoparticles , 2011, PloS one.

[76]  M. Morris,et al.  Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. , 2008, Advanced drug delivery reviews.

[77]  M. Pooga,et al.  Cell-penetrating Peptides Split into Two Groups Based on Modulation of Intracellular Calcium Concentration* , 2012, The Journal of Biological Chemistry.

[78]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[79]  T. Allen Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.

[80]  Christoph Patsch,et al.  The FASEB Journal Research Communication Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells , 2022 .

[81]  Azam Bolhassani,et al.  Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. , 2011, Biochimica et biophysica acta.

[82]  K. Doh,et al.  Homodimeric SV40 NLS peptide formed by disulfide bond as enhancer for gene delivery. , 2012, Bioorganic & medicinal chemistry letters.

[83]  M. Rhee,et al.  Mechanism of Uptake of C105Y, a Novel Cell-penetrating Peptide* , 2006, Journal of Biological Chemistry.

[84]  Yongzhuo Huang,et al.  TAT-modified nanosilver for combating multidrug-resistant cancer. , 2012, Biomaterials.

[85]  R. Tsien,et al.  Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases , 2010, Proceedings of the National Academy of Sciences.

[86]  J. J. Nestor,et al.  The medicinal chemistry of peptides. , 2009, Current medicinal chemistry.

[87]  M. Benincasa,et al.  Dual mode of action of Bac7, a proline-rich antibacterial peptide. , 2006, Biochimica et biophysica acta.

[88]  Dihua Yu,et al.  Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. , 1997, Cancer research.

[89]  Astrid Gräslund,et al.  Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.

[90]  Tae Gwan Park,et al.  Thermally triggered cellular uptake of quantum dots immobilized with poly(N-isopropylacrylamide) and cell penetrating peptide. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[91]  Yue-Wern Huang,et al.  Delivery of Nucleic Acids, Proteins, and Nanoparticles by Arginine-Rich Cell-Penetrating Peptides in Rotifers , 2013, Marine Biotechnology.

[92]  B. Wiesner,et al.  Extensive cellular uptake into endothelial cells of an amphipathic β‐sheet forming peptide , 1997, FEBS letters.

[93]  G. Bidwell,et al.  Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. , 2010, Advanced drug delivery reviews.

[94]  M. Morris,et al.  Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.

[95]  R. Lerner,et al.  A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library. , 2002, Bioorganic & medicinal chemistry.

[96]  Ülo Langel,et al.  Design of a Tumor-Homing Cell-Penetrating Peptide , 2008 .

[97]  F. Milletti,et al.  Cell-penetrating peptides: classes, origin, and current landscape. , 2012, Drug discovery today.

[98]  M. Giacca,et al.  Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[99]  Vladimir P Torchilin,et al.  Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[100]  Felix Kratz,et al.  Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative. , 2012, International journal of pharmaceutics.

[101]  R. Zhuo,et al.  Construction of cell penetrating peptide vectors with N-terminal stearylated nuclear localization signal for targeted delivery of DNA into the cell nuclei. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[102]  V. Torchilin,et al.  “Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes , 2007, Journal of liposome research.

[103]  P. Conti,et al.  In Vivo Near-Infrared Fluorescence Imaging of Integrin α2β1 in Prostate Cancer with Cell-Penetrating-Peptide–Conjugated DGEA Probe , 2011, The Journal of Nuclear Medicine.

[104]  Mark Bradley,et al.  Peptides for cell-selective drug delivery. , 2012, Trends in pharmacological sciences.

[105]  Vladimir P Torchilin,et al.  Cell-penetrating peptides: breaking through to the other side. , 2012, Trends in molecular medicine.

[106]  A. Jones,et al.  Cell entry of cell penetrating peptides: tales of tails wagging dogs. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[107]  M. Pooga,et al.  The membrane repair response masks membrane disturbances caused by cell‐penetrating peptide uptake , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[108]  X. Xue,et al.  Antisense inhibition of gene expression and growth in gram-negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene. , 2012, Biomaterials.

[109]  Vladimir P Torchilin,et al.  Enhanced transfection of tumor cells in vivo using “Smart” pH-sensitive TAT-modified pegylated liposomes , 2007, Journal of drug targeting.

[110]  E. Ruoslahti,et al.  Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[111]  J. Tam,et al.  Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. , 2002, Biochemistry.

[112]  Jeong Yu Lee,et al.  Intracellular delivery of paclitaxel using oil-free, shell cross-linked HSA--multi-armed PEG nanocapsules. , 2011, Biomaterials.

[113]  G. Verdine,et al.  An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides , 2000 .

[114]  Xiang-gao Meng,et al.  The effect of a nuclear localization sequence on transfection efficacy of genes delivered by cobalt(II)-polybenzimidazole complexes. , 2012, Biomaterials.

[115]  R. Brock,et al.  Biological responses towards cationic peptides and drug carriers. , 2011, Trends in pharmacological sciences.

[116]  A. Panitch,et al.  Thermosensitive nanoparticles with pH-triggered degradation and release of anti-inflammatory cell-penetrating peptides. , 2012, Biomacromolecules.

[117]  A. Zureikat,et al.  Targeted therapy for solid tumors: current status. , 2008, Surgical oncology clinics of North America.

[118]  P. Hammond,et al.  Controlling in vivo stability and biodistribution in electrostatically assembled nanoparticles for systemic delivery. , 2011, Nano letters.

[119]  You Han Bae,et al.  TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[120]  M. Giacca,et al.  Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. , 2005, The Biochemical journal.

[121]  W. Hennink,et al.  Delivery of Nucleic Acids , 2007, Pharmaceutical Research.

[122]  Weijun Su,et al.  CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma. , 2012, Biomaterials.

[123]  A. Kuliopulos,et al.  Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[124]  Astrid Gräslund,et al.  Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. , 2012, Accounts of chemical research.

[125]  E. Giralt,et al.  Proline-rich, amphipathic cell-penetrating peptides. , 2008, Advanced drug delivery reviews.

[126]  R. Brasseur,et al.  A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[127]  Jianping Zhou,et al.  Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. , 2012, Biomaterials.

[128]  G. Bidwell,et al.  Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. , 2007, Biochemical pharmacology.

[129]  E. Giralt,et al.  Amphipathic peptides and drug delivery. , 2004, Biopolymers.

[130]  Ű. Langel,et al.  Cell membrane translocation of the N-terminal (1-28) part of the prion protein. , 2002, Biochemical and biophysical research communications.

[131]  M. Ratnam,et al.  The folate receptor: What does it promise in tissue-targeted therapeutics? , 2007, Cancer and Metastasis Reviews.